Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology
7/31/2014 11:30:19 AM
AUSTIN, Texas--(BUSINESS WIRE)--Mystic Pharmaceuticals, Inc., a privately held, integrated specialty pharmaceutical company, announced today it has received a Notice of Allowance from the United States Patent Office for its “Medical Devices For Dispensing Powders” (application 13/433,586). Mystic’s latest innovation enables patient self administration of drugs and biologics formulated as powders for systemic nasal, nose-to-brain, ophthalmic, sublingual and buccal routes of administration.
Help employers find you! Check out all the jobs and post your resume.
comments powered by